AbCellera Biologics Inc. ( ABCL) - Key Metrics
ABCL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0.03 | -$0.13 | $0.08 | $0.08 |
| 2026Q2 | $0.01 | -$0.18 | -$0.11 | -$0.12 |
| 2026Q1 | $0.03 | -$0.14 | -$0.11 | -$0.12 |
| 2025Q4 | $0.15 | -$0.03 | -$0.12 | -$0.15 |
| 2025Q3 | $0.03 | -$0.19 | -$0.18 | -$0.21 |
ABCL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | -28.06 |
| 2026Q2 | 0% | -10.90 |
| 2026Q1 | 0% | -6.23 |
| 2025Q4 | 0% | -28.50 |
| 2025Q3 | 0% | -6.62 |
ABCL Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 0.55% | 0% |
| 2026Q2 | -1.50% | 0% |
| 2026Q1 | -3.53% | 0% |
| 2025Q4 | -4.36% | 0% |
| 2025Q3 | -4.09% | 0% |
ABCL
Price: $11.55
52 week price:
Earnings Per Share: -0.48 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 1.3 million
Market Capitalization: 3.9 billion